Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced the start of commercial production of lutetium-177. Lutetium-177 is a medical isotope used for targeted cancer therapies. The properties of the isotope allow it to bond with a … Read more
The week October 17th-21st, 2022 marked this year’s Nuclear Science Week (NSW), an international week-long celebration of all aspects of nuclear science. Held each October since 2010, NSW provides the opportunity to highlight innovation in nuclear and recognize the vital role it plays in the lives of people around the world. During NSW, many activities … Read more
Started in 1995, Promation quickly became an industry leader in automotive automation. Soon after, Promation leveraged its automation know-how and expanded into automation and tooling for nuclear applications for reactor maintenance, inspection, and refurbishment. Recently, Promation applied their knowledge of nuclear and automation to branch into the radiopharmaceutical industry. Promation now uses automation to developing … Read more
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for … Read more
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) alongside international and national industry associations covering a wide variety of nuclear applications. The NPT importantly … Read more
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes. This agreement will enable BWXT Medical to manufacture high purity Actinium-225 (Ac-225) … Read more
THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the organization and the broader Canadian Isotope Ecosystem. Reporting to the Executive Director, this position is responsible for public outreach, engagement, and education efforts. The specialist will also … Read more
Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum computing, neutron research, border security and medical imaging, is no exception. Laurentis Energy Partners is responding by stepping up its He-3 production … Read more
TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making Unit 7 the first power reactor in the world with installed capability to produce Lutetium-177 (Lu-177). Lu-177 is a medical isotope used in the treatment of … Read more
Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air Liquide for the distribution of Helium-3 (He-3), a rare isotope used in quantum computing, neutron research, border security and medical imaging. Laurentis recently announced its program to produce He-3 in Ontario before … Read more